Skip to main content
Top
Published in: World Journal of Surgical Oncology 1/2023

Open Access 01-12-2023 | Radiotherapy | Research

Clinicopathological characteristics and prognostic factors in axial chondroblastomas: a retrospective analysis of 61 cases and comparison with extra-axial chondroblastomas

Authors: Bo-Wen Zheng, Bo-Yv Zheng, Hua-Qing Niu, Ming-Xiang Zou, Hai-Lin Wu, Ming Wang, Xue-Lin Li

Published in: World Journal of Surgical Oncology | Issue 1/2023

Login to get access

Abstract

Background

A comprehensive understanding of the clinical characteristics and prognostic factors associated with axial chondroblastoma (ACB) is still lacking. This study aimed to understand the clinical characteristics and prognostic factors of axial chondroblastoma (ACB) and compare them with extra-axial chondroblastoma (EACB).

Methods

A retrospective review of our institution’s local database was conducted, encompassing a total of 132 CB patients, of which 61 were diagnosed with ACB and 71 with EACB. Immunohistochemistry was employed to evaluate the expression levels of vimentin, S100, and cytokeratin.

Results

ACB and EACB shared similar characteristics, with the exception of advanced age, tumor size, elevated Vim expression, incidence of surrounding tissue invasion, and postoperative sensory or motor dysfunction. While wide resection and absence of surrounding tissue invasion consistently showed a favorable association with survival in both ACB and EACB cohorts during univariate analysis, most parameters exhibited differential prognostic significance between the two groups. Notably, the significant prognostic factors for local recurrence-free survival in the ACB cohort included the type of resection and the presence of chicken-wire calcification. In the multivariate analysis of overall survival, the type of resection emerged as a significant predictor in the ACB cohort, whereas in the EACB group, the type of resection and the occurrence of postoperative sensory or motor dysfunction were predictive of overall survival.

Conclusion

There may exist distinct biological behaviors between ACB and EACB, thereby providing valuable insights into the prognostic characteristics of ACB patients and contributing to enhanced outcome prediction in this particular patient population.
Appendix
Available only for authorised users
Literature
1.
go back to reference Tathe SP, Parate SN, Jaiswal KN, Randale AA. Intraoperative crush smear cytology of vertebral chondroblastoma: a diagnostic challenge. Diagn Cytopathol. 2018;46(1):79–82.PubMedCrossRef Tathe SP, Parate SN, Jaiswal KN, Randale AA. Intraoperative crush smear cytology of vertebral chondroblastoma: a diagnostic challenge. Diagn Cytopathol. 2018;46(1):79–82.PubMedCrossRef
2.
go back to reference Angelini A, Hassani M, Mavrogenis AF, et al. Chondroblastoma in adult age. Eur J Orthop Surg Traumatol. 2017;27(6):843–9.PubMedCrossRef Angelini A, Hassani M, Mavrogenis AF, et al. Chondroblastoma in adult age. Eur J Orthop Surg Traumatol. 2017;27(6):843–9.PubMedCrossRef
3.
go back to reference Lin PP, Thenappan A, Deavers MT, Lewis VO, Yasko AW. Treatment and prognosis of chondroblastoma. Clin Orthop Relat Res. 2005;438:103–9.PubMedCrossRef Lin PP, Thenappan A, Deavers MT, Lewis VO, Yasko AW. Treatment and prognosis of chondroblastoma. Clin Orthop Relat Res. 2005;438:103–9.PubMedCrossRef
4.
go back to reference Xu H, Nugent D, Monforte HL, et al. Chondroblastoma of bone in the extremities: a multicenter retrospective study. J Bone Joint Surg Am. 2015;97(11):925–31.PubMedCrossRef Xu H, Nugent D, Monforte HL, et al. Chondroblastoma of bone in the extremities: a multicenter retrospective study. J Bone Joint Surg Am. 2015;97(11):925–31.PubMedCrossRef
5.
go back to reference Konishi E, Nakashima Y, Mano M, et al. Chondroblastoma of extra-craniofacial bones: clinicopathological analyses of 103 cases. Pathol Int. 2017;67(10):495–502.PubMedCrossRef Konishi E, Nakashima Y, Mano M, et al. Chondroblastoma of extra-craniofacial bones: clinicopathological analyses of 103 cases. Pathol Int. 2017;67(10):495–502.PubMedCrossRef
6.
go back to reference Laitinen MK, Stevenson JD, Evans S, et al. Chondroblastoma in pelvis and extremities - a single centre study of 177 cases. J Bone Oncol. 2019;17:100248.PubMedPubMedCentralCrossRef Laitinen MK, Stevenson JD, Evans S, et al. Chondroblastoma in pelvis and extremities - a single centre study of 177 cases. J Bone Oncol. 2019;17:100248.PubMedPubMedCentralCrossRef
7.
go back to reference Muhammed A, Meshneb M, Saro H, Elnakib N, Elnakib E. Management of cranial chondroblastoma in adults; a pooled analysis. Am J Otolaryngol. 2020;41(4):102486.PubMedCrossRef Muhammed A, Meshneb M, Saro H, Elnakib N, Elnakib E. Management of cranial chondroblastoma in adults; a pooled analysis. Am J Otolaryngol. 2020;41(4):102486.PubMedCrossRef
8.
go back to reference Venkatasamy A, Chenard MP, Massard G, Steib JP, Bierry G. Chondroblastoma of the thoracic spine: a rare location. Case report with radiologic-pathologic correlation. Skeletal Radiol. 2017;46(3):367–72.PubMedCrossRef Venkatasamy A, Chenard MP, Massard G, Steib JP, Bierry G. Chondroblastoma of the thoracic spine: a rare location. Case report with radiologic-pathologic correlation. Skeletal Radiol. 2017;46(3):367–72.PubMedCrossRef
9.
go back to reference Chung OM, Yip SF, Ngan KC, Ng WF. Chondroblastoma of the lumbar spine with cauda equina syndrome. Spinal Cord. 2003;41(6):359–64.PubMedCrossRef Chung OM, Yip SF, Ngan KC, Ng WF. Chondroblastoma of the lumbar spine with cauda equina syndrome. Spinal Cord. 2003;41(6):359–64.PubMedCrossRef
10.
11.
go back to reference Kim S, Cho K-J, Park Y, et al. Chondroblastoma of the lumbar spine - a case report and review of the literature. Korean J Pathol. 2011;45:532.CrossRef Kim S, Cho K-J, Park Y, et al. Chondroblastoma of the lumbar spine - a case report and review of the literature. Korean J Pathol. 2011;45:532.CrossRef
12.
go back to reference Zheng BW, Yang ML, Huang W, Zheng BY, Zhang TL, Li J, Lv GH, Yan YG, Zou MX. Prognostic significance of tumor-associated macrophages in chondroblastoma and their association with response to adjuvant radiotherapy. J Inflamm Res. 2021;17(14):1991–2005.CrossRef Zheng BW, Yang ML, Huang W, Zheng BY, Zhang TL, Li J, Lv GH, Yan YG, Zou MX. Prognostic significance of tumor-associated macrophages in chondroblastoma and their association with response to adjuvant radiotherapy. J Inflamm Res. 2021;17(14):1991–2005.CrossRef
13.
go back to reference Zheng BW, Zheng BY, Niu HQ, et al. Tumor growth rate in spinal giant cell tumors of bone and association with the immune microenvironment and denosumab treatment responsiveness: a multicenter study. Neurosurgery. 2023;92(3):524–37.PubMedCrossRef Zheng BW, Zheng BY, Niu HQ, et al. Tumor growth rate in spinal giant cell tumors of bone and association with the immune microenvironment and denosumab treatment responsiveness: a multicenter study. Neurosurgery. 2023;92(3):524–37.PubMedCrossRef
14.
go back to reference Zou MX, Lv GH, Wang XB, et al. Clinical impact of the immune microenvironment in spinal chordoma: immunoscore as an independent favorable prognostic factor. Neurosurgery. 2019;84(6):E318-e333.PubMedCrossRef Zou MX, Lv GH, Wang XB, et al. Clinical impact of the immune microenvironment in spinal chordoma: immunoscore as an independent favorable prognostic factor. Neurosurgery. 2019;84(6):E318-e333.PubMedCrossRef
15.
go back to reference Zou MX, Pan Y, Huang W, et al. A four-factor immune risk score signature predicts the clinical outcome of patients with spinal chordoma. Clin Transl Med. 2020;10(1):224–37.PubMedPubMedCentralCrossRef Zou MX, Pan Y, Huang W, et al. A four-factor immune risk score signature predicts the clinical outcome of patients with spinal chordoma. Clin Transl Med. 2020;10(1):224–37.PubMedPubMedCentralCrossRef
16.
go back to reference Liu FS, Zheng BW, Zhang TL, et al. Clinicopathological and prognostic characteristics in dedifferentiated/poorly differentiated chordomas: a pooled analysis of individual patient data from 58 studies and comparison with conventional chordomas. Front Oncol. 2021;11:686565.PubMedPubMedCentralCrossRef Liu FS, Zheng BW, Zhang TL, et al. Clinicopathological and prognostic characteristics in dedifferentiated/poorly differentiated chordomas: a pooled analysis of individual patient data from 58 studies and comparison with conventional chordomas. Front Oncol. 2021;11:686565.PubMedPubMedCentralCrossRef
17.
go back to reference Zheng BW, Huang W, Liu FS, Zhang TL, Wang XB, Li J, Lv GH, Yan YG, Zou MX. Clinicopathological and prognostic characteristics in spinal chondroblastomas: a pooled analysis of individual patient data from a single institute and 27 studies. Glob Spine J. 2021;26:21925682211005732. Zheng BW, Huang W, Liu FS, Zhang TL, Wang XB, Li J, Lv GH, Yan YG, Zou MX. Clinicopathological and prognostic characteristics in spinal chondroblastomas: a pooled analysis of individual patient data from a single institute and 27 studies. Glob Spine J. 2021;26:21925682211005732.
18.
go back to reference Du L, Li J, Lei L, et al. High vimentin expression predicts a poor prognosis and progression in colorectal cancer: a study with meta-analysis and TCGA Database. Biomed Res Int. 2018;2018:6387810.PubMedPubMedCentralCrossRef Du L, Li J, Lei L, et al. High vimentin expression predicts a poor prognosis and progression in colorectal cancer: a study with meta-analysis and TCGA Database. Biomed Res Int. 2018;2018:6387810.PubMedPubMedCentralCrossRef
19.
go back to reference Liu S, Liu L, Ye W, et al. High vimentin expression associated with lymph node metastasis and predicated a poor prognosis in oral squamous cell carcinoma. Sci Rep. 2016;6:38834.PubMedPubMedCentralCrossRef Liu S, Liu L, Ye W, et al. High vimentin expression associated with lymph node metastasis and predicated a poor prognosis in oral squamous cell carcinoma. Sci Rep. 2016;6:38834.PubMedPubMedCentralCrossRef
20.
go back to reference Tadokoro A, Kanaji N, Liu D, et al. Vimentin regulates invasiveness and is a poor prognostic marker in non-small cell lung cancer. Anticancer Res. 2016;36(4):1545–51.PubMed Tadokoro A, Kanaji N, Liu D, et al. Vimentin regulates invasiveness and is a poor prognostic marker in non-small cell lung cancer. Anticancer Res. 2016;36(4):1545–51.PubMed
21.
go back to reference Tanaka K, Tokunaga E, Inoue Y, et al. Impact of expression of vimentin and Axl in breast cancer. Clin Breast Cancer. 2016;16(6):520-526.e522.PubMedCrossRef Tanaka K, Tokunaga E, Inoue Y, et al. Impact of expression of vimentin and Axl in breast cancer. Clin Breast Cancer. 2016;16(6):520-526.e522.PubMedCrossRef
22.
go back to reference Shin CH, Roh JL, Song DE, et al. Prognostic value of tumor size and minimal extrathyroidal extension in papillary thyroid carcinoma. Am J Surg. 2020;220(4):925–31.PubMedCrossRef Shin CH, Roh JL, Song DE, et al. Prognostic value of tumor size and minimal extrathyroidal extension in papillary thyroid carcinoma. Am J Surg. 2020;220(4):925–31.PubMedCrossRef
23.
go back to reference Erdem S, Verep S, Bagbudar S, Ozluk Y, Sanli O, Ozcan F. The clinical predictive factors and postoperative histopathological parameters associated with upgrading after radical prostatectomy: a contemporary analysis with grade groups. Prostate. 2020;80(2):225–34.PubMedCrossRef Erdem S, Verep S, Bagbudar S, Ozluk Y, Sanli O, Ozcan F. The clinical predictive factors and postoperative histopathological parameters associated with upgrading after radical prostatectomy: a contemporary analysis with grade groups. Prostate. 2020;80(2):225–34.PubMedCrossRef
24.
go back to reference Bloem JL, Mulder JD. Chondroblastoma: a clinical and radiological study of 104 cases. Skeletal Radiol. 1985;14(1):1–9.PubMedCrossRef Bloem JL, Mulder JD. Chondroblastoma: a clinical and radiological study of 104 cases. Skeletal Radiol. 1985;14(1):1–9.PubMedCrossRef
25.
27.
go back to reference Jia Q, Liu C, Yang J, et al. Clinical features, treatments and long-term follow-up outcomes of spinal chondroblastoma: report of 13 clinical cases in a single center. J Neurooncol. 2018;140(1):99–106.PubMedCrossRef Jia Q, Liu C, Yang J, et al. Clinical features, treatments and long-term follow-up outcomes of spinal chondroblastoma: report of 13 clinical cases in a single center. J Neurooncol. 2018;140(1):99–106.PubMedCrossRef
28.
go back to reference Kao CH, Sun LM, Chen YS, et al. Risk of nongenitourinary cancers in patients with spinal cord injury: a population-based cohort study. Medicine (Baltimore). 2016;95(2):e2462.PubMedCrossRef Kao CH, Sun LM, Chen YS, et al. Risk of nongenitourinary cancers in patients with spinal cord injury: a population-based cohort study. Medicine (Baltimore). 2016;95(2):e2462.PubMedCrossRef
29.
go back to reference Zha J, Smith A, Andreansky S, Bracchi-Ricard V, Bethea JR. Chronic thoracic spinal cord injury impairs CD8+ T-cell function by up-regulating programmed cell death-1 expression. J Neuroinflammation. 2014;11:65.PubMedPubMedCentralCrossRef Zha J, Smith A, Andreansky S, Bracchi-Ricard V, Bethea JR. Chronic thoracic spinal cord injury impairs CD8+ T-cell function by up-regulating programmed cell death-1 expression. J Neuroinflammation. 2014;11:65.PubMedPubMedCentralCrossRef
30.
go back to reference Allison DJ, Ditor DS. Immune dysfunction and chronic inflammation following spinal cord injury. Spinal Cord. 2015;53(1):14–8.PubMedCrossRef Allison DJ, Ditor DS. Immune dysfunction and chronic inflammation following spinal cord injury. Spinal Cord. 2015;53(1):14–8.PubMedCrossRef
31.
go back to reference Demirhan H, Acioğlu E, Durna YM, Yiğit Ö, Bozkurt ER, Karagöz Y. Temporal bone localized chondroblastoma. J Craniofac Surg. 2015;26(8):e689-690.PubMedCrossRef Demirhan H, Acioğlu E, Durna YM, Yiğit Ö, Bozkurt ER, Karagöz Y. Temporal bone localized chondroblastoma. J Craniofac Surg. 2015;26(8):e689-690.PubMedCrossRef
32.
33.
go back to reference Zhou Y, Zhang J, Dan P, et al. Tumor calcification as a prognostic factor in cetuximab plus chemotherapy-treated patients with metastatic colorectal cancer. Anticancer Drugs. 2019;30(2):195–200.PubMedPubMedCentralCrossRef Zhou Y, Zhang J, Dan P, et al. Tumor calcification as a prognostic factor in cetuximab plus chemotherapy-treated patients with metastatic colorectal cancer. Anticancer Drugs. 2019;30(2):195–200.PubMedPubMedCentralCrossRef
34.
go back to reference Steitz SA, Speer MY, McKee MD, et al. Osteopontin inhibits mineral deposition and promotes regression of ectopic calcification. Am J Pathol. 2002;161(6):2035–46.PubMedPubMedCentralCrossRef Steitz SA, Speer MY, McKee MD, et al. Osteopontin inhibits mineral deposition and promotes regression of ectopic calcification. Am J Pathol. 2002;161(6):2035–46.PubMedPubMedCentralCrossRef
35.
go back to reference Rangaswami H, Bulbule A, Kundu GC. Osteopontin: role in cell signaling and cancer progression. Trends Cell Biol. 2006;16(2):79–87.PubMedCrossRef Rangaswami H, Bulbule A, Kundu GC. Osteopontin: role in cell signaling and cancer progression. Trends Cell Biol. 2006;16(2):79–87.PubMedCrossRef
36.
go back to reference John I, Inwards CY, Wenger DE, et al. Chondroblastomas presenting in adulthood: a study of 39 patients with emphasis on histological features and skeletal distribution. Histopathology. 2020;76(2):308–17.PubMedCrossRef John I, Inwards CY, Wenger DE, et al. Chondroblastomas presenting in adulthood: a study of 39 patients with emphasis on histological features and skeletal distribution. Histopathology. 2020;76(2):308–17.PubMedCrossRef
37.
go back to reference Vukasinović Z, Spasovski D, Slavković N, et al. Chondroblastoma–current opinion. Srp Arh Celok Lek. 2006;134(11–12):567–70.PubMed Vukasinović Z, Spasovski D, Slavković N, et al. Chondroblastoma–current opinion. Srp Arh Celok Lek. 2006;134(11–12):567–70.PubMed
38.
go back to reference Li F, Zhou K, Gao L, et al. Radiation induces the generation of cancer stem cells: a novel mechanism for cancer radioresistance. Oncol Lett. 2016;12(5):3059–65.PubMedPubMedCentralCrossRef Li F, Zhou K, Gao L, et al. Radiation induces the generation of cancer stem cells: a novel mechanism for cancer radioresistance. Oncol Lett. 2016;12(5):3059–65.PubMedPubMedCentralCrossRef
39.
go back to reference Sun T, Yang W, Toprani SM, et al. Induction of immunogenic cell death in radiation-resistant breast cancer stem cells by repurposing anti-alcoholism drug disulfiram. Cell Commun Signal. 2020;18(1):36.PubMedPubMedCentralCrossRef Sun T, Yang W, Toprani SM, et al. Induction of immunogenic cell death in radiation-resistant breast cancer stem cells by repurposing anti-alcoholism drug disulfiram. Cell Commun Signal. 2020;18(1):36.PubMedPubMedCentralCrossRef
41.
go back to reference Zheng BW, Liu FS, Zheng BY, et al. Risk factors for tuberculous or nontuberculous spondylitis after percutaneous vertebroplasty or kyphoplasty in patients with osteoporotic vertebral compression fracture: a case-control study. Front Surg. 2022;9:962425.PubMedPubMedCentralCrossRef Zheng BW, Liu FS, Zheng BY, et al. Risk factors for tuberculous or nontuberculous spondylitis after percutaneous vertebroplasty or kyphoplasty in patients with osteoporotic vertebral compression fracture: a case-control study. Front Surg. 2022;9:962425.PubMedPubMedCentralCrossRef
42.
go back to reference van der Vlies E, Los M, Stijns PEF, et al. Preoperative frailty and outcome in patients undergoing radical cystectomy. BJU Int. 2020;126(3):388–95.PubMedCrossRef van der Vlies E, Los M, Stijns PEF, et al. Preoperative frailty and outcome in patients undergoing radical cystectomy. BJU Int. 2020;126(3):388–95.PubMedCrossRef
43.
go back to reference Ko FC. Preoperative frailty evaluation: a promising risk-stratification tool in older adults undergoing general surgery. Clin Ther. 2019;41(3):387–99.PubMedPubMedCentralCrossRef Ko FC. Preoperative frailty evaluation: a promising risk-stratification tool in older adults undergoing general surgery. Clin Ther. 2019;41(3):387–99.PubMedPubMedCentralCrossRef
44.
go back to reference Cappe M, Laterre PF, Dechamps M. Preoperative frailty screening, assessment and management. Curr Opin Anaesthesiol. 2023;36(1):83–8.PubMedCrossRef Cappe M, Laterre PF, Dechamps M. Preoperative frailty screening, assessment and management. Curr Opin Anaesthesiol. 2023;36(1):83–8.PubMedCrossRef
Metadata
Title
Clinicopathological characteristics and prognostic factors in axial chondroblastomas: a retrospective analysis of 61 cases and comparison with extra-axial chondroblastomas
Authors
Bo-Wen Zheng
Bo-Yv Zheng
Hua-Qing Niu
Ming-Xiang Zou
Hai-Lin Wu
Ming Wang
Xue-Lin Li
Publication date
01-12-2023
Publisher
BioMed Central
Keyword
Radiotherapy
Published in
World Journal of Surgical Oncology / Issue 1/2023
Electronic ISSN: 1477-7819
DOI
https://doi.org/10.1186/s12957-023-03063-0

Other articles of this Issue 1/2023

World Journal of Surgical Oncology 1/2023 Go to the issue